Lifecore Biomedical
LFCR
LFCR
95 hedge funds and large institutions have $285M invested in Lifecore Biomedical in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.05% less ownership
Funds ownership: 88.57% → 86.53% (-2%)
11% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 35
95% less call options, than puts
Call options by funds: $13K | Put options by funds: $258K
Holders
95
Holding in Top 10
3
Calls
$13K
Puts
$258K
Top Buyers
| 1 | +$6.19M | |
| 2 | +$3.02M | |
| 3 | +$2.71M | |
| 4 |
SCM
SG Capital Management
Chicago,
Illinois
|
+$1.63M |
| 5 |
CSC
Cove Street Capital
El Segundo,
California
|
+$1.28M |
Top Sellers
| 1 | -$4.79M | |
| 2 | -$4.07M | |
| 3 | -$3.89M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.16M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.63M |